Virax Biolabs Group Limited - Ordinary Shares (VRAX)
1.6609
-0.0291 (-1.72%)
Virax Biolabs Group Limited is a biotechnology company focused on developing and commercializing innovative diagnostic solutions and therapeutics for viral infections, particularly in the fields of healthcare and disease prevention
The company leverages advanced technologies to create accurate diagnostic kits that aim to identify various viral pathogens, thereby aiding in effective disease management and treatment strategies. Virax is committed to enhancing global health outcomes by providing accessible and reliable testing solutions, which play a critical role in the early detection and monitoring of viral diseases.
Frequently Asked Questions
Is Virax Biolabs Group Limited - Ordinary Shares publicly traded?
Yes, Virax Biolabs Group Limited - Ordinary Shares is publicly traded.
What exchange does Virax Biolabs Group Limited - Ordinary Shares trade on?
Virax Biolabs Group Limited - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Virax Biolabs Group Limited - Ordinary Shares?
The ticker symbol for Virax Biolabs Group Limited - Ordinary Shares is VRAX on the Nasdaq Stock Market
What is the current price of Virax Biolabs Group Limited - Ordinary Shares?
The current price of Virax Biolabs Group Limited - Ordinary Shares is 1.661
When was Virax Biolabs Group Limited - Ordinary Shares last traded?
The last trade of Virax Biolabs Group Limited - Ordinary Shares was at 1:14 pm EST on January 31st, 2025